What 2025 Taught Us About Global Cannabis w/ Michael Sassano (SOMAÍ)
In this episode, Paul is joined by the Interim CEO and Founder of SOMAÍ Pharmaceuticals, Michael Sassano - a man with a track record for global market predictions. Together they look back at 2025, and explore what's in store across the world in 2026.
In this episode:
Trump Reschedules Cannabis in the US (1:30)
Not All Pharmaceuticals are the same (4:30)
Regulatory Curveballs across the world - UK, Germany and Australia (7:45)
Australia in 2025 (14:00)
Collaboration is the key to success (15:30)
The rise of emerging markets - France, Spain, Slovenia, Poland, New Zealand (19:00)
Preserving medicinal frameworks whilst achieving better access (24:00)
Operational challenges in Portugal in 2025 (28:30)
Meeting patient needs (31:00)
What’s coming in 2026 (34:30)
Patients need different formats (38:00)
Visit www.somaipharma.com.au
Visit www.giveandtoke.com.au
Follow @giveandtoke on Instagram
Email giveandtoke@gmail.com
